At a recent event organized by that consortium, the New Jersey Alliance for Clinical and Translational Science(NJACTS), leaders from academia, healthcare, government and the pharmaceutical industry discussed the future of scientific and clinical trial innovation in the state. These new innovations will result from a $33-million grant from the National Institutes of Health (NIH). To read the full story.
Recent Posts
- Could Hidden Infections Be Fueling Long COVID?
- Join NJ ACTS BERD on 1/22 for a Workshop with Dr. Yan Sun from NJIT
- How NJIT Graduate Student Jaimee Diogo Is Transforming STEM Futures Through ‘STEM Like a Girl’
- New Study Reveals Progress in Hospital Maternity Care Access in New Jersey, with Opportunities for Continued Improvement.
- Submit Your Proposal for Clinical Trials Days 2026
Categories
- Community (2,425)
- Covid (995)
- CTO Events (6)
- News (3,071)
- Pilots (21)